HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ira Pastan Selected Research

diphthamide

8/2015Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor.
4/2013A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Ira Pastan Research Topics

Disease

109Neoplasms (Cancer)
12/2015 - 02/2002
32Mesothelioma
12/2015 - 06/2002
25Hairy Cell Leukemia
12/2015 - 02/2002
14Pancreatic Neoplasms (Pancreatic Cancer)
02/2015 - 05/2005
13Ovarian Neoplasms (Ovarian Cancer)
05/2011 - 05/2002
12B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2014 - 02/2002
12Prostatic Neoplasms (Prostate Cancer)
01/2010 - 03/2002
10Leukemia
06/2014 - 04/2002
9Adenocarcinoma
05/2015 - 08/2003
8Breast Neoplasms (Breast Cancer)
08/2015 - 05/2002
8Neoplasm Metastasis (Metastasis)
05/2015 - 02/2002
7Hematologic Neoplasms (Hematological Malignancy)
04/2014 - 10/2006
7Lymphoma (Lymphomas)
04/2013 - 07/2002
7Glioma (Gliomas)
01/2013 - 01/2005
6Testicular Neoplasms (Testicular Cancer)
01/2012 - 03/2002
5Hemolytic-Uremic Syndrome
12/2015 - 09/2005
5Proteinuria
03/2015 - 04/2005
5Lung Neoplasms (Lung Cancer)
01/2014 - 06/2002
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2015 - 03/2010
4Glioblastoma (Glioblastoma Multiforme)
06/2015 - 05/2002
4Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2014 - 10/2006
4Brain Neoplasms (Brain Tumor)
01/2012 - 10/2003
4Carcinoma (Carcinomatosis)
03/2009 - 06/2002
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2007 - 06/2002
3Sclerosis
05/2014 - 04/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2013 - 06/2002
3Disease Progression
05/2012 - 06/2010
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
05/2012 - 01/2010
3B-Cell Lymphoma (Lymphoma, B Cell)
05/2012 - 11/2006
3Melanoma (Melanoma, Malignant)
07/2011 - 05/2002
3Infection
06/2009 - 09/2002
2Residual Neoplasm
12/2015 - 05/2006
2Ureteral Obstruction
04/2015 - 03/2011
2Thrombotic Microangiopathies
03/2015 - 09/2014
2Stomach Neoplasms (Stomach Cancer)
11/2014 - 02/2002
2Kidney Diseases (Kidney Disease)
05/2014 - 07/2012
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2013 - 07/2002
2T-Cell Lymphoma (Lymphoma, T Cell)
11/2013 - 05/2002
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
05/2012 - 05/2002
2Obesity
08/2011 - 01/2008

Drug/Important Bio-Agent (IBA)

86Immunotoxins (Immunotoxin)IBA
12/2015 - 02/2002
54megakaryocyte potentiating factorIBA
12/2015 - 06/2002
41AntigensIBA
06/2015 - 03/2002
18ExotoxinsIBA
06/2015 - 07/2002
17Proteins (Proteins, Gene)IBA
03/2015 - 04/2002
14AntibodiesIBA
01/2015 - 04/2002
12Monoclonal AntibodiesIBA
01/2015 - 06/2002
9Messenger RNA (mRNA)IBA
03/2015 - 03/2002
6MORAb-009IBA
11/2015 - 01/2007
6Membrane Glycoproteins (Membrane Glycoprotein)IBA
05/2015 - 11/2002
6EpitopesIBA
01/2015 - 04/2004
6Paclitaxel (Taxol)FDA LinkGeneric
11/2014 - 08/2006
6B3(Fv)-PE38KDEL recombinant immunotoxinIBA
01/2012 - 02/2002
5T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
12/2015 - 06/2008
5Surface Antigens (Surface Antigen)IBA
03/2015 - 04/2004
5SS1(dsFv)PE38IBA
11/2014 - 11/2002
5Staphylococcal Protein A (A, Protein)IBA
01/2014 - 07/2002
5HLA-A2 Antigen (HLA A2 Antigen)IBA
01/2013 - 04/2004
5RFB4(dsFv)-PE38 recombinant immunotoxinIBA
10/2011 - 01/2005
5Glycoproteins (Glycoprotein)IBA
07/2011 - 06/2002
5Membrane Proteins (Integral Membrane Proteins)IBA
04/2010 - 02/2003
4purineIBA
12/2015 - 02/2005
4Pentostatin (Nipent)FDA LinkGeneric
06/2014 - 10/2009
4Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/2013 - 10/2004
4Neutralizing AntibodiesIBA
01/2013 - 08/2008
4immunotoxin HA22IBA
06/2011 - 11/2006
4TARPIBA
06/2008 - 08/2003
4RNA (Ribonucleic Acid)IBA
05/2008 - 05/2002
3Immunoconjugates (Immunoconjugate)IBA
12/2015 - 12/2008
3epidermal growth factor receptor VIIIIBA
06/2015 - 05/2010
3Angiotensin IIIBA
04/2015 - 07/2012
3Immunoglobulin G (IgG)IBA
02/2015 - 05/2005
3Biological Markers (Surrogate Marker)IBA
11/2014 - 04/2012
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2014 - 06/2011
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2014 - 06/2002
3Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
05/2011 - 06/2002
3CladribineFDA LinkGeneric
10/2009 - 05/2006
3Serum AlbuminIBA
07/2007 - 02/2007
3IL13-PE38QQRIBA
07/2007 - 02/2007
3rituximab (Mabthera)FDA Link
10/2006 - 07/2002
3Transforming Growth Factor alpha (TGF-alpha)IBA
01/2005 - 10/2003
2CreatinineIBA
12/2015 - 05/2012
2VaccinesIBA
10/2015 - 04/2004
2diphthamideIBA
08/2015 - 04/2013
2Antigen Receptors (Antigen Receptor)IBA
06/2015 - 06/2014
2AngiotensinogenIBA
04/2015 - 07/2012
2tebufenozide (Mimic)IBA
01/2015 - 11/2006
2pemetrexed (MTA)FDA Link
12/2014 - 11/2014
2Cisplatin (Platino)FDA LinkGeneric
12/2014 - 11/2014
2nephrinIBA
05/2014 - 04/2010
2Protein Kinase CIBA
01/2013 - 05/2012
2Lewis Y antigenIBA
05/2012 - 02/2008
2Adenocarcinoma of lungIBA
05/2011 - 06/2002
2B-Lymphocyte Epitopes (B-Cell Epitope)IBA
04/2010 - 12/2006

Therapy/Procedure

22Immunotherapy
06/2015 - 03/2002
15Heterologous Transplantation (Xenotransplantation)
06/2015 - 10/2002
11Drug Therapy (Chemotherapy)
06/2015 - 01/2007
3Therapeutics
10/2015 - 01/2013
2Radioimmunotherapy
08/2012 - 07/2005
2Plasmapheresis
06/2009 - 09/2005